Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Mucolox for Oral Inflammatory Ulcerative Diseases
NCT04540133Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in oral lichen planus (OLP), mucous membrane pemphigoid (MMP), pemphigus vulgaris (PV), graft-versus-host disease (GVHD), sponsored by University of California, San Francisco. Started Dec 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
oral lichen planus (OLP)mucous membrane pemphigoid (MMP)pemphigus vulgaris (PV)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT04540133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540133.